New remote monitoring program aims to help epilepsy patients stick to treatment
NCT ID NCT07507240
First seen Apr 10, 2026 · Last updated Jun 18, 2026 · Updated 10 times
Summary
This study tests a new care pathway for people with epilepsy who are starting or switching anti-seizure medication. For six months, participants will be monitored remotely by a nurse to help detect side effects and seizure changes early. The goal is to improve medication adherence and quality of life until their next neurologist visit. The study involves 60 adults in France.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EPILEPSY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Cerebral electrophysiology, epilepsy and sleep, Purpan Hospital, Place du Docteur Baylac
Toulouse, Non, 31059, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.